Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

被引:4
|
作者
Yang, Cheng [1 ]
Wu, Yong-Jian [1 ]
Qian, Jie [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
关键词
statins; cardiovascular disease; lipid-lowering; cornerstone; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; LOWERING LDL CHOLESTEROL; RANDOMIZED CONTROLLED-TRIALS; CONSENSUS DECISION PATHWAY; CHRONIC KIDNEY-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; ISCHEMIC-STROKE;
D O I
10.31083/j.rcm2412373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis, the key pathogenesis of cardiovascular disease, is a leading cause of death and disability worldwide. Statins are first-line lipid-lowering drugs, which have been demonstrated to be powerful agents for anti-atherosclerosis. Numerous studies have confirmed the cardiovascular benefits and long-term safety of statins in a wide range of patients. Statins play an indispensable and irreplaceable part in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). In this article, we summarize the evolution of statins and their role in the treatment of cholesterol. The anti-atherosclerotic mechanism of statins, its efficacy, safety and clinical outcomes in secondary and primary prevention of ACSVD in different patient populations, the combination treatment effects, and guideline recommendations are also detailed. This paper highlights the profound significance of statins as the most successful anti-atherogenic drug in the cardiovascular field.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] AN INTERVENTION TO ENSURE PROPER STATIN DOSING IN PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
    Nabi, Wafa
    Zaidi, Danish
    Guan, Angel
    Joseph, Julia
    Sharninghausen, Jody
    Heard, Alex
    Wojtaszek, Danielle
    Zegarek, Matthew H.
    Brienza, Rebecca
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S328 - S328
  • [22] Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
    Mahtta, Dhruv
    Ramsey, David J.
    Al Rifai, Mahmoud
    Nasir, Khurram
    Samad, Zainab
    Aguilar, David
    Jneid, Hani
    Ballantyne, Christie M.
    Petersen, Laura A.
    Virani, Salim S.
    JAMA NETWORK OPEN, 2020, 3 (08)
  • [23] Beneficial effects of statin therapy on infection related mortality in patients with atherosclerotic and cardiovascular disease
    Mahajan, Rajesh
    Gupta, Rahul
    Sharma, Anju
    ANESTHESIA AND ANALGESIA, 2008, 106 (01): : 352 - 352
  • [24] Trends in statin initiation for secondary prevention of atherosclerotic cardiovascular disease among older adults
    Morris, Earl
    Ma, Kelly
    Reise, Rachel
    Tokatly, Nawaf
    Tortor, Cherry
    Vouri, Scott M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 385 - 386
  • [25] Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy
    Sampson, Maureen
    Wolska, Anna
    Amar, Marcelo
    Ueda, Masako
    Dunbar, Richard
    Soffer, Daniel
    Remaley, Alan T.
    CLINICAL CHEMISTRY, 2022, 68 (10) : 1302 - 1310
  • [26] Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease
    Wong, Nathan D.
    Zhao, Yanglu
    Xiang, Pin
    Coll, Blai
    Lopez, J. Antonio G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 137 : 7 - 11
  • [27] ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    不详
    ENDOCRINE PRACTICE, 2022, 28 (12)
  • [28] Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (40) : 6299 - 6305
  • [29] The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy
    Case, Brian C.
    Bress, Adam P.
    Kolm, Paul
    Philip, Sephy
    Herrick, Jennifer S.
    Granowitz, Craig B.
    Toth, Peter P.
    Fan, Wenjun
    Wong, Nathan D.
    Hull, Michael
    Weintraub, William S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (05) : 754 - 761
  • [30] Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women
    Borja-Hart, Nancy
    Graff, J. Carolyn
    Nolan, Vikki G.
    Wang, Jiajing
    Cooper-DeHoff, Rhonda M.
    Ancheta, Irma B.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (04) : 632 - 639